Adaptation of recombinant activated factor VII in the treatment of acquired haemophilia A: Results from a prospective study (ACQUI-7) in France

by Benoît Guillet, Achille Aouba, Annie Borel-Derlon, Jeanne Yvonne Borg, Jean-François Schved, Hélène Schneid, Hervé Lévesque
Published 2021-01-01

Management of a High-Risk Surgery with Emicizumab and Factor VIII in a Child with a Severe Hemophilia A and Inhibitor

by Charles R. Lefèvre, Anaïs Jaffré, Adeline Pontis, Fabienne Nedelec-Gac, Pierre Guéret, Isabelle Gouin-Thibault, Bernard Fraisse, Sophie Bayart, Benoit Guillet
Published 2021-04-01

Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?

by Quentin Allard, Zoubir Djerada, Claire Pouplard, Yohann Repessé, Dominique Desprez, Hubert Galinat, Birgit Frotscher, Claire Berger, Annie Harroche, Anne Ryman, Claire Flaujac, Pierre Chamouni, Benoît Guillet, Fabienne Volot, Jean Szymezak, Philippe Nguyen, Yoann Cazaubon
Published 2020-04-01